The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Nov. 04, 2014
Filed:
Apr. 01, 2011
Applicant:
Peter Nickolaus, Warthausen, DE;
Inventor:
Peter Nickolaus, Warthausen, DE;
Assignee:
Boehringer Ingelheim International GmbH, Ingelheim am Rhein, DE;
Attorneys:
Primary Examiner:
Int. Cl.
CPC ...
A61K 31/497 (2006.01); A61K 31/519 (2006.01); A61K 31/44 (2006.01); A61K 31/40 (2006.01); A61K 31/437 (2006.01); C07D 495/04 (2006.01); A61K 45/06 (2006.01); A61K 31/498 (2006.01); A61K 31/4745 (2006.01); A61K 31/55 (2006.01);
U.S. Cl.
CPC ...
A61K 31/519 (2013.01); A61K 31/437 (2013.01); A61K 31/44 (2013.01); C07D 495/04 (2013.01); A61K 45/06 (2013.01); A61K 31/498 (2013.01); A61K 31/4745 (2013.01); A61K 31/55 (2013.01);
Abstract
The present invention relates to new medicament combinations which contain in addition to one or more PDE4-inhibitors (1) at least one EP4 receptor antagonist (2), as well as the use thereof for the treatment of preferably respiratory complaints such as particularly COPD, chronic sinusitis and asthma. The invention relates in particular to those medicament combinations which contain at least one EP4 receptor antagonist (2), in addition to one or more, preferably one, PDE4 inhibitor of general formula 1 wherein X is SO or SO, but preferably SO, and wherein